Obesity: News

• ATTD 2025 GLP-1s Eyed as Key to Managing T1D With Obesity As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are increasingly viewed as adjuncts to insulin.
  Medscape Medical News, April 11, 2025
• Weight-Loss Surgery Instead of GLP-1s? In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a call to suggest patients consider surgery — or both.
  Medscape Medical News, April 11, 2025
• ACP-IM 2025 Eye-Opening Updates in Insomnia and OSA Expert shares treatment approaches for insomnia and alternatives for patients With PAP-intolerance.
  Medscape Medical News, April 11, 2025
• Sucralose Affects Brain Mechanisms That Regulate Appetite The noncaloric sweetener sucralose appears to influence how the hypothalamus interprets sweet taste and metabolic signals, potentially influencing appetite regulation over time.
  Medscape Medical News, April 10, 2025
• The Era of Compounded GLP-1 Drugs Is Over. What Now? Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.
  Medscape Medical News, April 10, 2025
• Cancer Deaths Fall in Europe, but Not Across All Types A new study has revealed significant reductions in cancer deaths across Europe, yet critical challenges persist for specific tumour types.
  Medscape News UK, April 10, 2025
• Surgery Tops Lifestyle Changes in Patients With Cirrhosis The cost-effectiveness of the surgery, particularly for those with cirrhosis, is significant compared with those only receiving a lifestyle modification program.
  Medscape Medical News, April 09, 2025
• Primary Care Practices See Steady Rise in Diabetes Cases As diabetes cases soar in the US, physicians are sounding the alarm, especially in economically challenged regions. The push for intensive screening and proactive management has never been more critical.
  Medscape Medical News, April 07, 2025
• USCAP 2025 Noninvasive Tests Unreliable in Assessing Liver Fibrosis Major discrepancies are seen with the use of noninvasive tests compared with liver biopsy in a posttransplant setting.
  Medscape Medical News, April 07, 2025
• Rhythm Pharma's Drug for Rare Obesity Meets Late-stage Trial Goal Rhythm Pharmaceuticals said on Monday its drug Imcivree notably reduced weight in patients with a rare obesity disorder caused by damage to the brain, meeting the main goal...
  Reuters Health Information, April 07, 2025
• What Else Can GLP-1 Drugs Do for Your Patients? How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, and neurological diseases.
  Medscape Medical News, April 07, 2025
• ACC 2025 WARRIOR Underscores Burden of Nonobstructive Angina in Women Because the trial ended up being underpowered, it did not show a benefit of intensive medical treatment, but there was a high rate of hospitalization in this population, which is not well understood.
  Medscape Medical News, April 04, 2025
• Helping GLP-1 Patients Focus on Fat Loss vs Weight Loss To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 agonists.
  Medscape Medical News, April 04, 2025
• When to Prescribe GLP-1s? Earlier Might Be Better While most guidelines require 6 months of behavioral interventions before prescribing weight-loss drugs, new research shows starting after 1 month improves outcomes.
  Medscape Medical News, April 03, 2025
• Is Percent Weight Loss the Right Obesity Treatment Target? New evidence suggests that factors other than the percentage of weight loss should be considered when determining the success of obesity-management efforts.
  Medscape Medical News, April 03, 2025
• Obesity ‘Strongly’ Linked to 16 Cardiometabolic Diseases The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep apnea, among others, increases with increasing BMI.
  Medscape Medical News, April 02, 2025
• Intermittent Fasting Beats Calorie Cutting for Weight Loss A 4:3 nonconsecutive intermittent fasting regimen was more tolerable and yielded somewhat greater weight loss at 1 year than daily caloric restriction.
  Medscape Medical News, April 02, 2025
• More Children Gaining Unhealthy Weight in Primary School More children in England are gaining excess weight during primary school than improving their BMI, a government analysis found.
  Medscape News UK, April 01, 2025
• Lilly Sues Two Compounders Over Copies Of Weight-loss Drugs Eli Lilly said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ingredient in its popular weight-loss and...
  Reuters Health Information, April 01, 2025
• Alert Benefits Outweigh Risks for Weight Loss Drug Mysimba The benefits of naltrexone/bupropion (Mysimba) continue to outweigh its risks, despite ongoing uncertainty about long-term cardiovascular safety, the EMA says.
  Medscape Medical News, March 28, 2025